Clinical Trial Update: Multiple CAR-T Cell Therapy Targeting AML [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reporting Phase 1 and Phase 2 studies of multiple CAR-T cell therapies targeting acute myeloid leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CAR-T cell therapy targeting acute myeloid leukemia (AML) - multiple candidates

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING